New research has again demonstrated the enormous value of the HPV vaccine, which protects against the virus responsible for more than 90% of cervical cancer cases.
Studies had already shown that the vaccine dramatically reduces rates of HPV infections and cervical cancer. Now comes evidence of what has long been suspected: The vaccine also saves lives.
That’s a message that needs reinforcing in the US, where vaccination rates continue to lag behind pre-pandemic levels — which were already behind health officials’ targets for population-level coverage. Officials will now contend with a new administration that is stacking its public health ...
Learn more about Bloomberg Law or Log In to keep reading:
See Breaking News in Context
Bloomberg Law provides trusted coverage of current events enhanced with legal analysis.
Already a subscriber?
Log in to keep reading or access research tools and resources.
